Single-head system to complement Picker's Prism XP linePicker International last week announced that it has acquiredScinticor, a Milwaukee-based manufacturer of cardiac gamma cameras,in a deal concluded Sept. 20. Terms of the acquisition were
Picker International last week announced that it has acquiredScinticor, a Milwaukee-based manufacturer of cardiac gamma cameras,in a deal concluded Sept. 20. Terms of the acquisition were notreleased.
Picker's interest in the company, whose major shareholder isMarquette Electronics of Milwaukee, was purely technological,said Josh Gurewitz, marketing manager for nuclear medicine atthe Cleveland-based vendor. Picker wanted to add Scinticor's single-headS1M-400 camera to its product line because the high count rateof the system enables exercise first-pass studies.
"Most gamma cameras count fast enough to do resting first-passstudies," Gurewitz said. "But the Scinticor camera isthe only one out there that can do exercise first-pass."
The first-pass cardiac exam done with exercise is a sensitiveindicator of cardiac disease, Gurewitz said. To be accurate, theproduct must have a very high count rate. The S1M-400 fits thebill, achieving in excess of one million counts per second, allowingscans to be completed in about one minute. Additionally, the examcan be done with a single injection of technetium, one of theleast costly isotopes on the market.
"Living in an era of managed care in the U.S., peopleare looking for low-cost, efficient, high-throughput systems thatcan quickly assess the patient's cardiac status," Gurewitzsaid. "That is exactly what this camera does."
To get comparable results, a patient would have to go througha stress perfusion study, a lengthy process calling for treadmillexercise and about a half-hour of imaging.
"We could look at 10 or 15 patients in that time and thechances are that if the patient is normal on a first-pass study,the perfusion is also normal, so they do not need the SPECT study,"he said.
Scinticor was formed in 1988 through a buyout of the nuclearmedicine business of Baird Corp. (SCAN 3/16/88). S1M-400 has beenon the market for several years, yet fewer than 200 of the camerashave been installed in the U.S., and even fewer internationally.The problem is not the technology, Gurewitz said.
"Scinticor is a relatively small company that does nothave very strong distribution channels and has only a small salesforce," Gurewitz said. "Visibility has not been there."
S1M-400 will get plenty of visibility as part of the Pickerproduct line, he said. Picker hopes to leverage sales of the camerain the cardiac arena among owners of its Prism XP gamma cameras,as well as to new customers. The product, which has an averageselling price of about $200,000, will be within the budget ofsmall community hospitals as well as large institutions.
Picker plans to continue using the name S1M-400 when the systemis integrated into the Prism XP product line. Picker does notexpect S1M-400 to conflict with sales of these cameras, Gurewitzsaid.
"We see this as a very nice combination with either ourdual-head camera or our triple-head cameras to do a complete nuclearcardiac assessment of the patient," Gurewitz said. "Anyoneinterested in doing accurate, quantitative exercise first-passstudies will need to look at the Scinticor device -- from Picker."
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.